Zenotech Laboratories

Zenotech Laboratories FCF Yield

The Free Cash Flow Yield of Zenotech Laboratories (532039.BO) as of Nov 22, 2026 is 0.66 %. In the previous year, Free Cash Flow Yield was 1.98 % — a change of -66.53% (lower).

FCF Yield

0.66 %

YoY

-66.53%

Last updated:

Free Cash Flow Yield of Zenotech Laboratories is 2026 0.66 % . Free Cash Flow Yield of Zenotech Laboratories was 2025 1.98 % . It decreases by -66.53% lower compared to the previous year.

The Zenotech Laboratories FCF Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Yield
Date
FCF Yield
Jan 1, 2019
-11.28 INR
Jan 1, 2020
-3.64 INR
Jan 1, 2021
0.29 INR
Jan 1, 2022
5.53 INR
Jan 1, 2023
5.07 INR
Jan 1, 2024
2.67 INR
Jan 1, 2025
1.98 INR
Jan 1, 2026
0.66 INR
The Zenotech Laboratories FCF Yield history
YEARFCF YieldYoY
0.66 %-66.53%
1.98 %-25.88%
2.67 %-47.42%
5.07 %-8.25%
5.53 %+1,796.31%
0.29 %-108.00%
-3.64 %-67.68%
-11.28 %+59.78%
-7.06 %-2,261.01%
0.33 %-119.33%
-1.69 %-38.12%
-2.73 %-55.55%
-6.14 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Zenotech Laboratories Stock analysis

What does Zenotech Laboratories do? Zenotech Laboratories Ltd manufactures and markets pharmaceutical products, specializing in oncology, biotechnology, and general injectables. The company operates from a manufacturing facility in Turkapally village, Shamirpet Mandal, Telangana, producing specialty generic injectables for the pharmaceutical sector. Its products are sold to healthcare providers and distributors within the pharmaceutical industry, targeting markets that require specialized injectable solutions. The firm's business model focuses on the production and distribution of generic injectables, leveraging its facility in Telangana to serve both domestic and international markets. By concentrating on oncology and biotechnology injectables, Zenotech addresses specific medical needs, generating revenue through the sale of these high-demand pharmaceutical products to hospitals, clinics, and pharmaceutical distributors. Zenotech Laboratories Ltd's revenue streams come from the sale of its specialty generic injectables, including oncology and biotechnology products, to healthcare institutions and distribution networks. The company's manufacturing capabilities in Telangana support its role as a supplier in the pharmaceutical supply chain, with a focus on injectable formulations that cater to critical healthcare applications. Zenotech Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Zenotech Laboratories stock

Free Cash Flow Yield of Zenotech Laboratories is 0.66 % in 2026.

Free Cash Flow Yield of Zenotech Laboratories changed from 1.98 % to 0.66 %, representing a -66.53% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Yield Zenotech Laboratories since 2006 – with annual values, charts, and detailed analysis.

FCF Yield measures the free cash flow per share relative to the stock price. It indicates how much cash a company generates for each dollar invested.

To evaluate Free Cash Flow Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Yield's Zenotech Laboratories with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Zenotech Laboratories

All Key Metrics — Zenotech Laboratories